A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation
Clinical trial NCT03781219 · UNKNOWN
Trial details
- NCT number
- NCT03781219
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2023-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.